These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 39081703)
1. Tongxieyaofang Decotion Alleviates IBS by Modulating CHRM3 and Gut Barrier. Feng T; Zhou Y; Lv B; Cai L Drug Des Devel Ther; 2024; 18():3191-3208. PubMed ID: 39081703 [TBL] [Abstract][Full Text] [Related]
2. Tong-Xie-Yao-Fang improves intestinal permeability in diarrhoea-predominant irritable bowel syndrome rats by inhibiting the NF-κB and notch signalling pathways. Hou Q; Huang Y; Zhu Z; Liao L; Chen X; Han Q; Liu F BMC Complement Altern Med; 2019 Nov; 19(1):337. PubMed ID: 31775739 [TBL] [Abstract][Full Text] [Related]
3. The inhibitory effect of tongxieyaofang on rats with post infectious irritable bowel syndrome through regulating colonic par-2 receptor. Hu X; Zhang X; Han B; Bei W BMC Complement Altern Med; 2013 Oct; 13():246. PubMed ID: 24088410 [TBL] [Abstract][Full Text] [Related]
4. Tong-Xie-Yao-Fang strengthens intestinal feedback control of bile acid synthesis to ameliorate irritable bowel syndrome by enhancing bile salt hydrolase-expressing microbiota. Jia F; Du L; He J; Zhang Z; Hou X; Dong Q; Bian Z; Zhao L J Ethnopharmacol; 2024 Sep; 331():118256. PubMed ID: 38677571 [TBL] [Abstract][Full Text] [Related]
5. WenTongGanPi decoction alleviates diarrhea-predominant irritable bowel syndrome by improving intestinal barrier. Li Y; Chen Y; Liao Z; Liu Y; Liu C; Yang W; Bai J; Huang X; Hao Y; Liu S; Liu Y J Ethnopharmacol; 2024 Nov; 334():118544. PubMed ID: 39013542 [TBL] [Abstract][Full Text] [Related]
6. Using ultra-performance liquid chromatography with linear ion trap-electrostatic field orbitrap mass spectrometry, network pharmacology, and molecular docking to explore the constituent targets and action mechanisms of decoction of Angelica sinensis, Zingiberis Rhizoma Recens, and Mutton in the treatment of diarrhea-predominant irritable bowel syndrome. Liu Z; Zheng Z; Wang T; Liu Z; Zuo Z J Pharm Pharmacol; 2024 May; 76(5):462-478. PubMed ID: 37832514 [TBL] [Abstract][Full Text] [Related]
7. Chang-Kang-Fang alleviates diarrhea predominant irritable bowel syndrome (IBS-D) through inhibiting TLR4/NF-κB/NLRP3 pathway. Zhang S; Tian D; Xia Z; Yang F; Chen Y; Yao Z; He Y; Miao X; Zhou G; Yao X; Tang J J Ethnopharmacol; 2024 Aug; 330():118236. PubMed ID: 38670405 [TBL] [Abstract][Full Text] [Related]
8. Exploring the Mechanisms of Self-made Kuiyu Pingchang Recipe for the Treatment of Ulcerative Colitis and Irritable Bowel Syndrome using a Network Pharmacology-based Approach and Molecular Docking. Wen Y; Wang X; Si K; Xu L; Huang S; Zhan Y Curr Comput Aided Drug Des; 2024; 20(5):534-550. PubMed ID: 37190808 [TBL] [Abstract][Full Text] [Related]
9. Sinisan Alleviates Stress-Induced Intestinal Dysfunction and Depressive-like Behaviors in Mice with Irritable Bowel Syndrome by Enhancing the Intestinal Barrier and Modulating Central 5-Hydroxytryptamine. Zeng H; Jiang Y; Yin Q; Li X; Xiong Y; Li B; Xu X; Hu H; Qian G Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408592 [TBL] [Abstract][Full Text] [Related]
10. Tong-Xie-Yao-Fang alleviates diarrhea-predominant irritable bowel syndrome in rats via the GCN2/PERK-eIF2α-ATF4 signaling pathway. Zhang M; Zheng Y; Li X; Wu H; Liu P; Zhang K; Shi Z; Lv M; Wang F; Tang X Phytomedicine; 2022 Dec; 107():154350. PubMed ID: 36194974 [TBL] [Abstract][Full Text] [Related]
11. Regulating effect of TongXie-YaoFang on colonic epithelial secretion Yang C; Xiong Y; Zhang SS; An FM; Sun J; Zhang QL; Zhan Q World J Gastroenterol; 2016 Dec; 22(48):10584-10591. PubMed ID: 28082810 [TBL] [Abstract][Full Text] [Related]
12. Atractylodes oil alleviates diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and intestinal barrier via SCF/c-kit and MLCK/MLC2 pathways. Xie Y; Zhan X; Tu J; Xu K; Sun X; Liu C; Ke C; Cao G; Zhou Z; Liu Y J Ethnopharmacol; 2021 May; 272():113925. PubMed ID: 33592255 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of TongXie-YaoFang formula on colonic contraction in rats. Yang C; Zhang SS; Li XL; Wang ZF; Zhao LQ World J Gastroenterol; 2015 Mar; 21(10):2912-7. PubMed ID: 25780288 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of the Chinese herbal formula TongXieYaoFang for irritable bowel syndrome: a systematic review. Bian Z; Wu T; Liu L; Miao J; Wong H; Song L; Sung JJ J Altern Complement Med; 2006 May; 12(4):401-7. PubMed ID: 16722791 [TBL] [Abstract][Full Text] [Related]
15. The mechanisms of action of WeiChang'An Pill (WCAP) treat diarrhoea-predominant irritable bowel syndrome (IBS-D) using network pharmacology approach and in vivo studies. Chen Y; Chu F; Lin J; Su Z; Liao M; Li T; Li Y; Johnson N; Zheng H; Ding X J Ethnopharmacol; 2021 Jul; 275():114119. PubMed ID: 33862102 [TBL] [Abstract][Full Text] [Related]
16. [Efficacy and mechanism of acupuncture combined with Wang SS; Wang XR; Yang RY; Xu Y; Li MY Zhongguo Zhen Jiu; 2020 Jun; 40(6):605-9. PubMed ID: 32538010 [TBL] [Abstract][Full Text] [Related]
17. Network pharmacology and molecular docking reveal the immunomodulatory mechanism of rhubarb peony decoction for the treatment of ulcerative colitis and irritable bowel syndrome. Zhai L; Yang W; Li D; Zhou W; Cui M; Yao P J Pharm Pharm Sci; 2023; 26():11225. PubMed ID: 37305432 [No Abstract] [Full Text] [Related]
18. Deciphering the synergistic network regulation of active components from SiNiSan against irritable bowel syndrome via a comprehensive strategy: Combined effects of synephrine, paeoniflorin and naringin. Cai T; Wang X; Li B; Xiong F; Wu H; Yang X Phytomedicine; 2021 Jun; 86():153527. PubMed ID: 33845366 [TBL] [Abstract][Full Text] [Related]
19. [Research on the mechanism of shengxian and jinshuiliujun decoction in treating silicosis based on network pharmacology]. Tang YW; Zhang XX; Wu BB; Zhao LY; Shen X; Shen FH Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2024 Jul; 42(7):487-497. PubMed ID: 39075002 [No Abstract] [Full Text] [Related]
20. Tong Xie Yao Fang relieves irritable bowel syndrome in rats via mechanisms involving regulation of 5-hydroxytryptamine and substance P. Yin Y; Zhong L; Wang JW; Zhao XY; Zhao WJ; Kuang HX World J Gastroenterol; 2015 Apr; 21(15):4536-46. PubMed ID: 25914462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]